Functions of Lipids for Enhancement of Oral Bioavailability of Poorly Water-Soluble Drugs 723 Acknowledgements The work has been supported by the KLE University, J.N medical college, Belgaum, Karnataka. Authors’ Statement Competing Interests The authors declare no conflict of interest. References [1] [2] [3] [4] [5] [6] [7] [8] Stuchlik M, Stanislav Z. Lipid based vehicle for oral drug delivery. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2001; 145: 17–26. http://www.ncbi.nlm.nih.gov/pubmed/12426768 Hauss DJ. Oral lipid-based formulations. Adv Drug Deliv Rev. 2007; 59: 667–676. http://dx.doi.org/10.1016/j.addr.2007.05.006 Schneider M. Investigation of the transport of lipophilic drugs in structurally diverse lipid formulations through caco-2 cell monolayer using mathematical modeling. PhD Thesis, University of Basel, Switzerland, 2008. Humberstone AJ, Charman WN. Lipid-based vehicles for the oral delivery of poorly water-soluble drugs. Adv Drug Deliv Rev. 1997; 25: 103–128. http://dx.doi.org/10.1016/S0169-409X(96)00494-2 Kossena GK, Charman WN, Boyd BJ, Dunstan DE, Porter CJH. Predicting drug solubilization patterns in the gastrointestinal tract after administration of lipid based delivery systems: A phase diagram approach. J Pharm Sci. 2004; 93: 332–348. http://dx.doi.org/10.1002/jps.10554 Shackleford DM, Porter CJH, Charman WN. Problems addressable by prodrugs. In: Stell VJ, Borchardt RT, Hageman MJ, Oliyai R, Maag H, Tilley JW; Eds. Prodrugs: Challenges and Rewards. Springer, 2006: AAPS Press, 657. http://dx.doi.org/10.1007/978-0-387-49785-3_18 Dahan A, Hoffman A. Rationalizing and selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water-soluble drugs. J Control Release. 2007; 129: 1–10. http://dx.doi.org/10.1016/j.jconrel.2008.03.021 Charman WN, Porter CJH, Mithani S, Dressman JB. Physicochemical and physiological mechanisms for the effects of food on drug absorption: The role of lipids and pH. J Pharm Sci. 2000; 86: 269–282. http://dx.doi.org/10.1021/js960085v Sci Pharm. 2011; 79: 705–727